TaiRx (6580.TWO) Stock Price

TaiRx Price

CLOSED
14.60
​
Market closed

Revenue has compounded at 51.8% per year over the past 7 years to 27.88 M TWD. TaiRx's net margin stands at -793.3%, up from -2,443.4% several years earlier.

TaiRx stock price

Access this data via the Eulerpool API

TaiRx business model & stock analysis

TaiRx, Inc. engages in the research and development of novel drug products for cancer treatment. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-06-20. The firm primarily focus on the research and development of cancer treatment drugs and sepsis adjuvant therapy drugs. The firm's main products include CVM-1118, Rexis, Zelnite, TRX-NOC, TRX-920, TRX-711, TRX-105 and others. CVM-1118 and Rexis are in clinical trials, and Zelnite drugs are sold to domestic medical institutions at all levels through distributors.

Frequently asked questions about TaiRx

Converted at the current exchange rate, the TaiRx share trades at 0.41 EUR (14.60 TWD).

The revenue cannot currently be calculated for TaiRx.

The profit cannot currently be calculated for TaiRx.

The P/E ratio cannot be calculated for TaiRx at the moment.

The P/S cannot be calculated for TaiRx currently.

The Eulerpool Quality Score for TaiRx is 4/10.

The ISIN of TaiRx is TW0006580004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of TaiRx is 6580.TWO. The ticker symbol is used to trade TaiRx shares on the stock exchange.

Fair ValueTerminal
12.56 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website trx.com.tw
Country
Taiwan
Currency
TWD
Initial public offering
Jun 20, 2017
ISIN
TW0006580004
Cusip
Y8400U105
Market capitalization
1.64 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
3.71
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-50.08 %
Last updated Oct 8, 2026, 10:07 AM

TaiRx Peer Group

TaiRx FIGI

6580:TT (Taipei Stock Exchange) · BBG00GXCGGC5

All fundamentals and in-depth analysis of TaiRx

Our stock analysis for TaiRx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TaiRx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.